Moreover, a recent study reported that STAT3 phosphorylation can mediate the effect of IFN-α on B-cell differentiation and activation in SLE,[28] which may lead to the identification of new targets for SLE treatment. This evidence concerns the gene STAT3 and systemic lupus erythematosus.